Cargando…
Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria
INTRODUCTION: Sub-Saharan Africa houses over two-thirds of the 37 million people living with human immunodeficiency virus (HIV) globally and of this, 5–20% are co-infected with Hepatitis B virus (HBV). This is double jeopardy, especially for women of reproductive age in these settings, who can trans...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498243/ https://www.ncbi.nlm.nih.gov/pubmed/32941424 http://dx.doi.org/10.1371/journal.pone.0236456 |
_version_ | 1783583468239716352 |
---|---|
author | Adeyemi, Olusegun Adewale Itanyi, Ijeoma Uchenna Ozigbu, Chamberline Ekene Stadnick, Nicole Tsuyuki, Kiyomi Olayiwola, Olanrewaju Ogidi, Amaka Grace Eze, Chuka Aarons, Gregory Alan Onoka, Chima Ariel Ezeanolue, Echezona Edozie |
author_facet | Adeyemi, Olusegun Adewale Itanyi, Ijeoma Uchenna Ozigbu, Chamberline Ekene Stadnick, Nicole Tsuyuki, Kiyomi Olayiwola, Olanrewaju Ogidi, Amaka Grace Eze, Chuka Aarons, Gregory Alan Onoka, Chima Ariel Ezeanolue, Echezona Edozie |
author_sort | Adeyemi, Olusegun Adewale |
collection | PubMed |
description | INTRODUCTION: Sub-Saharan Africa houses over two-thirds of the 37 million people living with human immunodeficiency virus (HIV) globally and of this, 5–20% are co-infected with Hepatitis B virus (HBV). This is double jeopardy, especially for women of reproductive age in these settings, who can transmit both viruses vertically as well as horizontally to their children. The objectives of this study were to investigate the prevalence and determinants of HBV among women of reproductive age living with HIV. METHODS: This was a cross-sectional study of HIV-infected women of reproductive age in Benue State, Nigeria. Participants were eligible for the study if they were HIV-infected women (ages 18–45 years) receiving care from any of the selected study sites. A global rapid hepatitis B surface antigen (HBsAg) antibody test strip was used to test for HBsAg in plasma. A pretested questionnaire was used to collect data on sociodemographic, clinical and lifestyle characteristics of participants. We estimated prevalence of HBV infection and used multivariable logistic regression to determine factors associated with the infection at a significance level of <0.05. RESULTS: A total of 6577 women were screened for HBsAg. The prevalence of HBV was 10.3% (95% CI: 9.5–10.9%). Age, parity and male partner’s HIV status were found to be associated with having HBV infection. Compared to women older than 40 years, the odds of HBV infection increased significantly with increasing age until age 35 years and decreased significantly with increasing parity (versus no parity). Women with HIV-infected partners and those without a partner had higher odds of HBV infection compared to women with HIV-negative partners. CONCLUSION: HBV is hyperendemic among HIV-infected women of reproductive age in North Central Nigeria. Specific programs targeting HBV testing, vaccination and treatment of all women of reproductive age need to be developed in this resource-limited, high-need setting. |
format | Online Article Text |
id | pubmed-7498243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-74982432020-09-24 Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria Adeyemi, Olusegun Adewale Itanyi, Ijeoma Uchenna Ozigbu, Chamberline Ekene Stadnick, Nicole Tsuyuki, Kiyomi Olayiwola, Olanrewaju Ogidi, Amaka Grace Eze, Chuka Aarons, Gregory Alan Onoka, Chima Ariel Ezeanolue, Echezona Edozie PLoS One Research Article INTRODUCTION: Sub-Saharan Africa houses over two-thirds of the 37 million people living with human immunodeficiency virus (HIV) globally and of this, 5–20% are co-infected with Hepatitis B virus (HBV). This is double jeopardy, especially for women of reproductive age in these settings, who can transmit both viruses vertically as well as horizontally to their children. The objectives of this study were to investigate the prevalence and determinants of HBV among women of reproductive age living with HIV. METHODS: This was a cross-sectional study of HIV-infected women of reproductive age in Benue State, Nigeria. Participants were eligible for the study if they were HIV-infected women (ages 18–45 years) receiving care from any of the selected study sites. A global rapid hepatitis B surface antigen (HBsAg) antibody test strip was used to test for HBsAg in plasma. A pretested questionnaire was used to collect data on sociodemographic, clinical and lifestyle characteristics of participants. We estimated prevalence of HBV infection and used multivariable logistic regression to determine factors associated with the infection at a significance level of <0.05. RESULTS: A total of 6577 women were screened for HBsAg. The prevalence of HBV was 10.3% (95% CI: 9.5–10.9%). Age, parity and male partner’s HIV status were found to be associated with having HBV infection. Compared to women older than 40 years, the odds of HBV infection increased significantly with increasing age until age 35 years and decreased significantly with increasing parity (versus no parity). Women with HIV-infected partners and those without a partner had higher odds of HBV infection compared to women with HIV-negative partners. CONCLUSION: HBV is hyperendemic among HIV-infected women of reproductive age in North Central Nigeria. Specific programs targeting HBV testing, vaccination and treatment of all women of reproductive age need to be developed in this resource-limited, high-need setting. Public Library of Science 2020-09-17 /pmc/articles/PMC7498243/ /pubmed/32941424 http://dx.doi.org/10.1371/journal.pone.0236456 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Adeyemi, Olusegun Adewale Itanyi, Ijeoma Uchenna Ozigbu, Chamberline Ekene Stadnick, Nicole Tsuyuki, Kiyomi Olayiwola, Olanrewaju Ogidi, Amaka Grace Eze, Chuka Aarons, Gregory Alan Onoka, Chima Ariel Ezeanolue, Echezona Edozie Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria |
title | Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria |
title_full | Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria |
title_fullStr | Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria |
title_full_unstemmed | Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria |
title_short | Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria |
title_sort | sero-prevalence and determinants of hepatitis b among a cohort of hiv-infected women of reproductive age in nigeria |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498243/ https://www.ncbi.nlm.nih.gov/pubmed/32941424 http://dx.doi.org/10.1371/journal.pone.0236456 |
work_keys_str_mv | AT adeyemiolusegunadewale seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT itanyiijeomauchenna seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT ozigbuchamberlineekene seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT stadnicknicole seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT tsuyukikiyomi seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT olayiwolaolanrewaju seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT ogidiamakagrace seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT ezechuka seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT aaronsgregoryalan seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT onokachimaariel seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria AT ezeanolueechezonaedozie seroprevalenceanddeterminantsofhepatitisbamongacohortofhivinfectedwomenofreproductiveageinnigeria |